Page last updated: 2024-09-04

docetaxel anhydrous and Cecal Diseases

docetaxel anhydrous has been researched along with Cecal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colucci, G; Dejaco, H; Grones, A; Marsoner, H; Thaler, W1
Cardenal, F; Llort, G; Mesía, R; Montes, A; Seguí, J1

Reviews

1 review(s) available for docetaxel anhydrous and Cecal Diseases

ArticleYear
Colonic rupture in a patient on combination chemotherapy for metastasized carcinoma of the esophagogastric junction. Case report and review of the literature.
    Onkologie, 2005, Volume: 28, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cecal Diseases; Cisplatin; Colonic Diseases; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Humans; Intestinal Perforation; Middle Aged; Rupture; Stomach Neoplasms; Taxoids; Treatment Outcome

2005

Other Studies

1 other study(ies) available for docetaxel anhydrous and Cecal Diseases

ArticleYear
Typhlitis associated with docetaxel treatment.
    Journal of the National Cancer Institute, 1996, Aug-07, Volume: 88, Issue:15

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cecal Diseases; Docetaxel; Enterocolitis, Pseudomembranous; Fatal Outcome; Humans; Ileal Diseases; Lung Neoplasms; Male; Middle Aged; Necrosis; Paclitaxel; Taxoids

1996
chemdatabank.com